42
iX Biopharma Ltd.
42C.SI · SES
$0.57 -5.00% (-$0.03)
1M +14.00%
Market Cap $656.0M
P/E Ratio -
Div. Yield -
ROE 136.58%
Piotroski F-Score Moderate
6/9Valuation
0 /100
Expensive P/S 95.72x
P/B 42.61x
P/E N/A
Growth
39 /100
Stable Rev. growth 5.04%
Book val. growth 0.97%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 35.52%
Net margin 116.64%
Op. margin 139.52%
Quality
3 /100
Poor ROIC 44.73%
ROE 136.58%
ROA 30.89%
Debt
65 /100
Moderate Debt/Equity 0.38x
Current ratio 1.86x
Int. coverage -13.86x
Stability
60 /100
Moderate Beta 1.10x
Rev. volatility 21.62%
EPS volatility 20.90%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 42C.SI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Yip Hang Lee
Employees
35
Headquarters
Singapore